1. Home
  2. QTEXW vs NVNO Comparison

QTEXW vs NVNO Comparison

Compare QTEXW & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QTEXW

QTREX Quantum Ltd. Warrant

N/A

Current Price

$0.07

Market Cap

6.4M

Sector

Health Care

ML Signal

N/A

Logo enVVeno Medical Corporation

NVNO

enVVeno Medical Corporation

HOLD

Current Price

$11.36

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTEXW
NVNO
Founded
N/A
1987
Country
Israel
United States
Employees
N/A
33
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
7.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
QTEXW
NVNO
Price
$0.07
$11.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
35.7K
6.7K
Earning Date
N/A
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$140.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.30
52 Week High
$0.12
$13.44

Technical Indicators

Market Signals
Indicator
QTEXW
NVNO
Relative Strength Index (RSI) 45.44 57.79
Support Level $0.01 $9.78
Resistance Level $0.10 $12.84
Average True Range (ATR) 0.04 0.76
MACD 0.00 0.07
Stochastic Oscillator 53.45 62.55

Price Performance

Historical Comparison
QTEXW
NVNO

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the advancement of bioprosthetic (tissue-based) solutions to improve the standard of care for the treatment of venous disease. The company first developed the VenoValve, which was a surgical replacement venous valve. It is focused on its next-generation, non-surgical venous valve product, called the enVVe System which consists of the enVVe Valve, enVVe Delivery System, enVVe Nose Cone, the enVVe Delivery System Accessories, and the enVVe Crimping System. The enVVe System is designed to treat severe deep chronic venous insufficiency through a minimally invasive, catheter-based approach. It operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: